GO:0030026 intracellular manganese ion homeostasis: Transport and Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030026 describes the biological process that maintains a steady-state level of manganese ions (Mn2+) inside the cell, balancing uptake, storage, trafficking, and efflux [1,8].
• Manganese is an essential cofactor for enzymes such as mitochondrial superoxide dismutase (SOD2), arginase, and glycosyltransferases, so its intracellular concentration must be tightly controlled [1,8].
• Key transporters and pumps, including SLC39A8 (ZIP8), SLC30A10 (ZnT10), SLC39A14 (ZIP14), and SPCA1 (ATP2C1), mediate Mn2+ entry, compartmentalization, and export [4,8].
• Disrupted manganese homeostasis is linked to neurotoxicity, liver disease, and cancer, with mutations in SLC30A10 and SLC39A14 causing inherited manganese transport disorders [1,4].
• The Golgi apparatus and mitochondria are major intracellular manganese stores and signaling hubs, and their ion homeostasis is critical for health and disease [3,4].
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the causal roles of manganese homeostasis genes in physiology and disease.
Description
Intracellular manganese ion homeostasis (GO:0030026) is the biological process that maintains a steady-state level of manganese ions (Mn2+) within the cell [1,8]. Manganese is an essential trace metal that serves as a cofactor for a wide range of enzymes, including mitochondrial superoxide dismutase (SOD2), arginase, and glycosyltransferases, and it also participates in immune signaling and redox balance [1,8]. Because both deficiency and excess of manganese can be harmful, cells have evolved sophisticated transport and buffering systems to keep cytosolic and organellar Mn2+ concentrations within a narrow physiological range [1,8]. Research into GO:0030026 has accelerated in recent years due to the discovery of dedicated manganese transporters and the recognition that manganese dysregulation contributes to human diseases such as neurodegeneration, liver cirrhosis, and cancer [1,4]. The Golgi apparatus and mitochondria are particularly important intracellular manganese compartments, and their ion homeostasis is tightly linked to secretory function and oxidative stress responses [3,4]. Understanding how cells achieve manganese homeostasis is therefore fundamental to metal biology, neurobiology, and oncology. This article provides a research-grade overview of GO:0030026, covering its definition, molecular mechanisms, key genes, disease relevance, and the experimental methods—including CRISPR-based models—used to study it. All statements are based on published literature and authoritative GO annotations.
intracellular manganese ion homeostasis At A Glance
| GO ID | GO:0030026 |
|---|---|
| GO term | intracellular manganese ion homeostasis |
| Ontology | biological_process |
| Synonym | cellular manganese ion homeostasis; manganese homeostasis |
| Definition | A homeostatic process involved in the maintenance of a steady state level of manganese ions within a cell. |
| Major function | Maintains cytosolic and organellar Mn2+ concentrations within physiological limits for enzyme cofactor supply and toxicity prevention. |
| Key transporters | SLC39A8 (ZIP8), SLC39A14 (ZIP14), SLC30A10 (ZnT10), ATP2C1 (SPCA1), and others [4,8]. |
| Subcellular locations | Cytosol, mitochondria, Golgi apparatus, lysosomes, and endoplasmic reticulum [3,4]. |
| Disease relevance | Manganese transport disorders, neurodegeneration, liver disease, and cancer [1,4]. |
What Is GO:0030026?
GO:0030026, intracellular manganese ion homeostasis, is defined as a homeostatic process involved in the maintenance of a steady state level of manganese ions within a cell [1,8]. It encompasses all cellular activities that sense, transport, chelate, store, and export Mn2+ to prevent toxic accumulation or deficiency. This process operates in the cytosol and within organelles such as mitochondria and the Golgi apparatus, and it is distinct from systemic manganese homeostasis, which involves whole-body absorption and excretion [1,8].
Why Is intracellular manganese ion homeostasis Important in Cell Biology?
Intracellular manganese ion homeostasis is essential because manganese is both an indispensable enzyme cofactor and a potential neurotoxin when in excess [1,8]. Cells must therefore precisely balance manganese uptake, intracellular trafficking, storage, and efflux to support metalloenzyme function while avoiding oxidative stress and organelle dysfunction [1,8]. Disruption of this balance is increasingly recognized as a driver of human pathology, including inherited manganese transport diseases, Parkinsonism, liver cirrhosis, and tumor progression [1,4]. Studying GO:0030026 provides mechanistic insight into metal biology and identifies therapeutic targets for metal-related disorders.
• Manganese is a required cofactor for SOD2, arginase, and glycosyltransferases, making its homeostasis vital for antioxidant defense and metabolism [1,8].
• Excess intracellular manganese causes neurotoxicity and manganism, a Parkinson-like syndrome.
• Mutations in SLC30A10 and SLC39A14 cause inherited disorders of manganese transport with severe neurological and hepatic phenotypes [1,4].
• The Golgi apparatus requires manganese for glycosylation and secretory functions, and its ion homeostasis is linked to disease [3,4].
• Manganese homeostasis influences immune responses and redox signaling, with implications for cancer immunotherapy.
• Dysregulated manganese handling contributes to oxidative stress in inflammatory bowel disease and other inflammatory conditions.
• Manganese-based chemistry is being explored for programmed cell death induction in cancer therapy.
• Understanding manganese homeostasis aids in interpreting metal-related toxicity and designing chelation or supplementation strategies [1,8].
• CRISPR screens can identify novel regulators of intracellular manganese homeostasis.
• Manganese homeostasis intersects with aging and bone repair through redox and NAD+ balance.
What Happens During intracellular manganese ion homeostasis?
Manganese uptake across the plasma membrane
In simple terms: Cells take in manganese from the outside through specialized transporter proteins.
Manganese enters cells primarily via transporters such as SLC39A8 (ZIP8) and SLC39A14 (ZIP14), which are members of the ZIP family of metal ion transporters [4,8]. These transporters mediate the influx of Mn2+ and other divalent metals, and their expression levels are regulated in response to cellular manganese status. Uptake is the first step in maintaining intracellular manganese homeostasis, and its dysregulation can lead to manganese overload or deficiency [1,4].
Intracellular trafficking and organellar storage
In simple terms: Once inside, manganese is moved to different compartments where it is stored or used.
After entering the cytosol, manganese is trafficked to organelles including mitochondria, the Golgi apparatus, and lysosomes [3,4]. The Golgi apparatus is a major manganese store, where the ion is required for glycosyltransferase activity, and its homeostasis is maintained by transporters such as ATP2C1 (SPCA1) [3,4]. Mitochondria also accumulate manganese for SOD2 function, and mitochondrial manganese transport is critical for antioxidant defense. This compartmentalization prevents toxic cytosolic accumulation and ensures cofactor availability [1,8].
Manganese efflux and detoxification
In simple terms: When there is too much manganese, cells pump it out or sequester it to avoid damage.
To prevent manganese toxicity, cells export Mn2+ via transporters such as SLC30A10 (ZnT10), which functions as a manganese efflux pump [4,8]. SLC30A10 is localized to the plasma membrane and Golgi, and its loss leads to manganese accumulation and neurotoxicity [1,4]. Efflux is a key regulatory node in intracellular manganese homeostasis, and its failure is associated with inherited manganese transport disorders [1,4].
Manganese sensing and transcriptional regulation
In simple terms: Cells sense manganese levels and adjust gene expression to keep things balanced.
Cells sense intracellular manganese status and modulate the expression of transporters and chelators to restore homeostasis. For example, manganese-responsive transcription factors and post-transcriptional mechanisms can alter the levels of SLC39A8, SLC39A14, and SLC30A10. This feedback regulation ensures that manganese concentrations remain within a narrow physiological range despite fluctuating environmental availability [1,8].
Manganese as a signaling ion in redox and immune responses
In simple terms: Manganese also acts as a signal that helps control oxidative stress and immune reactions.
Beyond its role as an enzyme cofactor, manganese participates in redox homeostasis and immune signaling. For instance, intracellular manganese can act as an immune ion reactor, modulating redox balance and enhancing antitumor immune responses. Manganese also influences programmed cell death pathways, and its intracellular chemistry is being harnessed for cancer therapy. These signaling functions are tightly linked to manganese homeostasis [6,7].
Key Genes Involved in GO:0030026 intracellular manganese ion homeostasis
The following genes encode proteins that directly participate in or regulate intracellular manganese ion homeostasis, as supported by published literature [1,4,8].
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC39A8 (ZIP8) | Manganese uptake transporter at the plasma membrane [4,8] | Knockout reduces manganese influx; linked to manganese deficiency and immune dysfunction. |
| SLC39A14 (ZIP14) | Manganese uptake transporter, especially in liver and brain [4,8] | Mutations cause childhood-onset manganese transport disorder [1,4]. |
| SLC30A10 (ZnT10) | Manganese efflux pump; prevents overload [4,8] | Loss-of-function causes hypermanganesemia with dystonia and liver disease [1,4]. |
| ATP2C1 (SPCA1) | Golgi manganese pump; maintains Golgi Mn2+ for glycosylation [3,4] | Defects alter Golgi homeostasis and secretory function. |
| SOD2 | Mitochondrial superoxide dismutase requiring Mn2+ cofactor [1,8] | Manganese availability affects SOD2 activity and oxidative stress. |
| ARG1 | Arginase requiring Mn2+ for urea cycle | Manganese homeostasis impacts arginase activity and nitrogen metabolism. |
| TFR1 (TFRC) | Transferrin receptor; may influence manganese uptake indirectly | Iron and manganese transport intersect; useful for metal crosstalk studies. |
| DMT1 (SLC11A2) | Divalent metal transporter; can transport Mn2+ | Contributes to manganese uptake in some cell types. |
| MT1A (Metallothionein) | Cysteine-rich metal-binding protein; can chelate manganese | Modulates intracellular manganese buffering and toxicity. |
| ATP13A2 (PARK9) | Lysosomal transporter implicated in manganese homeostasis | Mutations linked to Kufor-Rakeb syndrome and Parkinsonism. |
| SLC30A1 (ZnT1) | Zinc transporter with potential manganese efflux activity | May contribute to manganese detoxification. |
| CNNM proteins | Metal transporters that may influence Mn2+ homeostasis | Candidate regulators of intracellular manganese. |
| SMF1/SMF2 (yeast homologs) | Manganese transporters in model organisms | Used to study evolutionary conservation of manganese homeostasis. |
| PMR1 (yeast SPCA1 homolog) | Golgi manganese pump in yeast | Model for Golgi manganese homeostasis and glycosylation. |
| NRAMP1 (SLC11A1) | Natural resistance-associated macrophage protein; transports Mn2+ | Links manganese homeostasis to innate immunity. |
| HIF-1α | Transcription factor regulated by redox and manganese | Manganese influences HIF-1α signaling and immune responses. |
| NF-κB | Inflammatory transcription factor modulated by manganese | Manganese homeostasis affects NF-κB activation in inflammation. |
| Nrf2 | Antioxidant transcription factor responsive to manganese-induced stress | Manganese homeostasis intersects with Nrf2-mediated redox control. |
How Is intracellular manganese ion homeostasis Regulated?
Intracellular manganese ion homeostasis is regulated at multiple levels. Transcriptional control of transporters such as SLC39A8, SLC39A14, and SLC30A10 adjusts uptake and efflux in response to manganese status. Post-translational mechanisms, including protein trafficking and degradation, also modulate transporter abundance. Manganese itself can influence signaling pathways such as NF-κB and Nrf2, which in turn affect redox homeostasis and inflammatory responses. Additionally, manganese homeostasis is intertwined with iron and zinc metabolism, as transporters like DMT1 and ZIP proteins handle multiple metals. In the Golgi, ATP2C1 (SPCA1) activity is regulated by pH and ion gradients, which are critical for secretory function. Overall, regulation ensures that manganese concentrations remain within a narrow range to support metalloenzyme activity without causing toxicity [1,8].
intracellular manganese ion homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC30A10 | Hypermanganesemia with dystonia, liver cirrhosis [1,4] | Knockout HepG2 or primary hepatocytes; point mutation knock-in in mice. |
| SLC39A14 | Childhood-onset manganese transport disorder [1,4] | Knockout HEK293 or neuronal cells; knock-in of patient mutations. |
| ATP2C1 | Hailey-Hailey disease; Golgi dysfunction | Knockout keratinocytes; overexpression of wild-type vs. mutant SPCA1. |
| SOD2 | Oxidative stress, neurodegeneration [1,8] | Knockout or point mutation (Mn-binding site) in cell lines; rescue with Mn supplementation. |
| SLC39A8 | Manganese deficiency, immune dysfunction | Knockout immune cells; overexpression for uptake studies. |
Manganese transport disorders and neurodegeneration
Mutations in SLC30A10 and SLC39A14 cause inherited disorders of manganese homeostasis characterized by hypermanganesemia, dystonia, Parkinsonism, and liver cirrhosis [1,4]. These conditions highlight the critical role of proper manganese efflux and uptake in neuroprotection. Additionally, chronic environmental manganese exposure can lead to manganism, a Parkinson-like syndrome, underscoring the importance of intracellular manganese regulation in the brain.
Manganese homeostasis in cancer and immune responses
Manganese homeostasis influences tumor progression and immune surveillance. Intracellular manganese can act as an immune ion reactor, modulating redox balance and enhancing antitumor immune responses. Manganese-based chemistry is also being explored to induce programmed cell death in cancer cells. Dysregulated manganese transport may therefore represent a therapeutic vulnerability in oncology [6,7].
Golgi manganese homeostasis and secretory disease
The Golgi apparatus requires manganese for glycosylation and secretory functions, and its ion homeostasis is maintained by transporters such as ATP2C1 (SPCA1) [3,4]. Disruption of Golgi manganese homeostasis can lead to defects in protein glycosylation and secretory pathway function, contributing to diseases such as Hailey-Hailey disease (caused by ATP2C1 mutations) and other secretory disorders.
Manganese and inflammatory/oxidative stress conditions
Manganese homeostasis is linked to oxidative stress and inflammation. In inflammatory bowel disease, nanocomposites that scavenge oxidative stress and restore gut immune homeostasis have been shown to modulate manganese-related redox balance. Manganese also affects NF-κB and Nrf2 signaling, which are central to inflammatory responses. Thus, targeting manganese homeostasis may offer therapeutic benefits in inflammatory diseases.
From intracellular manganese ion homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC30A10 cause intracellular manganese accumulation? | CRISPR knockout of SLC30A10 in HepG2 or HeLa cells, followed by ICP-MS [1,4]. |
| Do patient mutations in SLC39A14 impair manganese transport? | Point mutation knock-in of patient variants in HEK293 cells. |
| Can overexpression of SLC39A8 increase manganese uptake? | Overexpression of SLC39A8 in HEK293 or HeLa cells, measure Mn2+ influx. |
| What is the role of ATP2C1 in Golgi manganese homeostasis? | Knockout of ATP2C1 in HeLa cells; complement with tagged SPCA1. |
| Does manganese homeostasis affect immune signaling? | Knockout of SLC39A8 in macrophages; measure NF-κB and cytokine production. |
| Can manganese-based compounds induce programmed cell death? | Overexpression of manganese transporters in cancer cells; treat with Mn-based agents. |
How to Study the intracellular manganese ion homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ICP-MS | Total intracellular manganese concentration | Validation of knockout/overexpression effects on manganese levels [1,4]. |
| Fluorescent sensors (e.g., Manganese Green) | Real-time cytosolic or organellar Mn2+ dynamics | Live-cell imaging of transport activity [3,4]. |
| RNA-seq | Global transcriptional changes | Identifying manganese-responsive genes and pathways. |
| Proteomics | Protein abundance and post-translational modifications | Discovering manganese-dependent protein networks. |
| CRISPR knockout screens | Genes required for manganese homeostasis | Unbiased discovery of novel regulators. |
| CRISPR activation screens | Genes whose overexpression alters manganese sensitivity | Identifying protective or toxic modifiers. |
| Subcellular fractionation + ICP-MS | Manganese content in organelles (mitochondria, Golgi) | Assessing compartment-specific homeostasis [3,4]. |
| Glycosylation assays | Golgi function dependent on manganese | Evaluating impact of ATP2C1 mutations. |
Inductively coupled plasma mass spectrometry (ICP-MS)
ICP-MS is the gold standard for quantifying intracellular manganese concentrations. It measures total manganese content in cell lysates or subcellular fractions, allowing researchers to assess the impact of genetic perturbations on manganese homeostasis [1,4]. This method is essential for validating knockout or overexpression phenotypes.
Fluorescent manganese sensors and imaging
Genetically encoded fluorescent sensors (e.g., Manganese sensors) and small-molecule dyes enable real-time imaging of intracellular Mn2+ dynamics. These tools can reveal compartment-specific changes in manganese levels and are useful for studying transport kinetics and organellar homeostasis [3,4].
Transcriptomics and proteomics
RNA-seq and proteomics can identify global changes in gene expression and protein abundance upon manipulation of manganese homeostasis genes. These approaches help uncover feedback networks and novel regulators of GO:0030026.
CRISPR library screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate intracellular manganese levels or sensitivity to manganese stress. Such screens are powerful for discovering new components of manganese homeostasis pathways.
How CRISPR Can Be Used to Study GO:0030026 intracellular manganese ion homeostasis
Knockout
CRISPR knockout of manganese homeostasis genes such as SLC30A10, SLC39A14, or ATP2C1 allows researchers to study loss-of-function phenotypes, including intracellular manganese accumulation, oxidative stress, and organelle dysfunction [1,4]. Knockout cell lines are valuable for validating gene function and for drug screening.
Point Mutation
Point mutation knock-in can replicate patient-specific mutations in manganese transporters, such as those found in SLC30A10 or SLC39A14, to dissect the molecular basis of transport defects and disease severity. These models are ideal for testing allele-specific therapies.
Knock-in
Knock-in of tagged versions of manganese transporters (e.g., GFP-SLC30A10) enables live-cell imaging and proteomic analysis of protein localization and interactions [3,4]. Knock-in of reporter genes can also be used to monitor transporter expression dynamics.
Overexpression
Overexpression of manganese transporters or chelators (e.g., SLC39A8, metallothionein) can increase or buffer intracellular manganese levels, allowing gain-of-function studies [4,8]. Overexpression models are useful for testing whether increased manganese uptake or efflux alters cell survival, redox balance, or immune signaling [6,7].
How EDITGENE Supports intracellular manganese ion homeostasis Research
Researchers studying intracellular manganese ion homeostasis-related genes often need to determine whether a candidate gene is causally involved in manganese transport, toxicity, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of GO:0030026.
Contact EDITGENE today to design your custom CRISPR model for intracellular manganese ion homeostasis research.
Frequently Asked Questions About intracellular manganese ion homeostasis
What is intracellular manganese ion homeostasis?
Intracellular manganese ion homeostasis (GO:0030026) is the biological process that maintains a steady-state level of manganese ions within a cell, balancing uptake, storage, trafficking, and efflux to support enzyme function and prevent toxicity [1,8].
What genes are involved in intracellular manganese ion homeostasis?
Key genes include SLC39A8 (ZIP8), SLC39A14 (ZIP14), SLC30A10 (ZnT10), ATP2C1 (SPCA1), SOD2, and metallothioneins, among others [1,4,8].
Why is manganese important for cells?
Manganese is a cofactor for enzymes such as SOD2, arginase, and glycosyltransferases, and it participates in redox and immune signaling [1,8].
What happens when manganese homeostasis is disrupted?
Disruption can lead to manganese toxicity or deficiency, causing neurotoxicity, liver disease, and immune dysfunction [1,4].
Which diseases are linked to manganese transport defects?
Mutations in SLC30A10 and SLC39A14 cause inherited manganese transport disorders with Parkinsonism and liver cirrhosis [1,4].
How is intracellular manganese measured?
ICP-MS is used to quantify total manganese, while fluorescent sensors enable real-time imaging of Mn2+ dynamics [3,4].
What is the role of the Golgi in manganese homeostasis?
The Golgi stores manganese for glycosylation and secretory functions, maintained by transporters like ATP2C1 (SPCA1) [3,4].
Can CRISPR be used to study manganese homeostasis?
Yes, CRISPR knockout, knock-in, and overexpression models allow precise manipulation of manganese homeostasis genes for functional studies.
What are the symptoms of manganese toxicity?
Symptoms include Parkinson-like movement disorders, cognitive deficits, and liver damage.
How does manganese affect the immune system?
Manganese can act as an immune ion reactor, modulating redox balance and enhancing antitumor immune responses.
Conclusion
Intracellular manganese ion homeostasis (GO:0030026) is a fundamental biological process that ensures the proper balance of manganese for enzyme function while preventing toxicity. Advances in understanding its molecular mechanisms, key transporters, and disease links have highlighted its importance in neurobiology, hepatology, and oncology [1,4,8]. Continued research using CRISPR-based models and advanced analytical methods will further elucidate how cells maintain manganese homeostasis and how its dysregulation contributes to human disease.
References
- 1. Chen P et al.. 2018. Manganese metabolism in humans.. Front Biosci (Landmark Ed) 23(9):1655-1679 PMID: 29293455
- 2. Jiang J et al.. 2026. A senescent metabolism-modulating hierarchical scaffold restores NAD(+) homeostasis and redox balance for aged bone repair.. Bioact Mater 66:78-90 PMID: 42395338
- 3. Khosrowabadi E et al.. 2023. Golgi pH and Ion Homeostasis in Health and Disease.. Rev Physiol Biochem Pharmacol 185:1-23 PMID: 32870398
- 4. Li J et al.. 2022. Golgi Metal Ion Homeostasis in Human Health and Diseases.. Cells 11(2) PMID: 35053405
- 5. Zhang X et al.. 2025. Yeast-Inspired Orally-Administered Nanocomposite Scavenges Oxidative Stress and Restores Gut Immune Homeostasis for Inflammatory Bowel Disease Treatment.. ACS Nano 19(7):7350-7369 PMID: 39943645
- 6. You Y et al.. 2025. Intracellular metal ion-based chemistry for programmed cell death.. Chem Soc Rev 54(3):1552-1582 PMID: 39744985
- 7. Feng Y et al.. 2022. Intracellular marriage of bicarbonate and Mn ions as "immune ion reactors" to regulate redox homeostasis and enhanced antitumor immune responses.. J Nanobiotechnology 20(1):193 PMID: 35440088
- 8. Roth J et al.. 2013. Manganese homeostasis and transport.. Met Ions Life Sci 12:169-201 PMID: 23595673
